GlaxoSmithKline Pharmaceuticals Ltd

Share capital reconciliation

• Quarter ended 30 September 2026: reconciliation filed under Regulation 76.
• Issued capital: 16,94,15,420; Listed capital: 16,94,06,034 shares.
• Dematerialised holdings: NSDL 16,28,10,133; CDSL 55,35,251; Physical 10,60,650.
• Total shares: 16,94,06,034; 99.99% of issued capital listed.
• Shares moved to IEPF: 60,466 under Section 124(6).
• Register of Members updated; common registrar: KFin Technologies Limited.
• Auditor: Manish Ghia & Associates; Compliance officer: Ajay A. Nadkarni.

Meeting Details

• Board meeting scheduled for Tuesday, 3 November 2026; time and location not disclosed.

Key Agenda Items

• Consider and approve unaudited financial results for Q2 and the half-year ended 30 September 2026.

GlaxoSmithKline Pharmaceuticals Limited: Trading Window closed from 1 October 2026 till 48 hours after the unaudited financial results for the quarter and half-year ended 30 September 2026 are announced.

Resolution 1: Natland Non-Executive Director (Ordinary)

• Approved: Karine Natland appointed Non-Executive Director; 143,066,813 votes for, 419,550 against (99.71%/0.29%).

Resolution 2: Bhushan Akshikar Reappointed MD (Ordinary)

• Approved: Bhushan Akshikar reappointed as Managing Director; 143,025,237 votes for, 415,465 against (99.71%/0.29%).

Corrigendum details

• Corrigendum to Postal Ballot Notice dated 3 August 2026 issued to correct remuneration figure.
• Corrects typographical error in Explanatory Statement; basic salary reads Rs 24,00,000 per month.
• Corrigendum forms integral part of the Notice together with the Explanatory Statement.
• Corrigendum issued 1 September 2026; emailed to members and will be published in newspapers.
• Notice circulated to Members on 13 August 2026.
• Basic salary corrected to Rs 24,00,000 per month (not Rs 24,00,0000).
• Corrigendum uploaded on company website.
• Notice will be read with this Corrigendum; other contents unchanged.

Remuneration corrigendum

• Corrects Mr. Akshikar's monthly basic salary to Rs 24,00,000 per month.
• Corrigendum forms integral part of the Notice and Explanatory Statement.
• Corrigendum issued Sept 1, 2026; relates to August 3, 2026 postal ballot notice.
• Notice originally circulated August 13, 2026; corrigendum updates related remuneration details.

Volume rise clarified

• Volume rise deemed market-driven; no undisclosed information.
• Company has disclosed all material information as per SEBI LODR Regulation 30.
• Will continue to comply with listing requirements and inform exchanges of price-sensitive updates.

Tax refund under Sec 143(1) AY 2025-2026

• Intimation under Sec 143(1) received for AY 2025-2026; refund of Rs 49,911,100.
• Refund credited to bank on 18 Aug 2026; intimation dated 19 Aug 2026.
• Tax refund to be recognised as Tax Paid Asset in Balance Sheet.
• No violations or contraventions mentioned in the filing.
• Signed by Ajay Nadkarni, VP Administration, Real Estate & Company Secretary.